Concepedia

Bettina Lawrenz

BL

Statistics

Publications

8

Citations

659

H-Index

8

Active since

2010

Affiliations

Bayer (Germany)(Current)

Martin Luther University Halle-Wittenberg

University of Potsdam

Charité - Universitätsmedizin Berlin

Bettina Lawrenz is an author at Bayer (Germany) specializing in medicine, pharmacology, and molecular pharmacology.

Publications per year

2010–2024

8

Publications

8

Mechanistic Investigations of the Mitochondrial Complex I Inhibitor Rotenone in the Context of Pharmacological and Safety Evaluation

Sabrina Heinz, Alexius Freyberger, Bettina Lawrenz et al. · Scientific Reports · 2017 · 323 citations · Full text

Medicine, Oncology, Pharmacology +17

Soluble Guanylate Cyclase Stimulation Prevents Fibrotic Tissue Remodeling and Improves Survival in Salt-Sensitive Dahl Rats

Sandra Geschka, Axel Kretschmer, Yuliya Sharkovska et al. · PLoS ONE · 2011 · 102 citations · Full text

Medicine, Cardiology, Pharmacology +16

Nitric oxide-independent stimulation of soluble guanylate cyclase reduces organ damage in experimental low-renin and high-renin models

Yuliya Sharkovska, Philipp Kalk, Bettina Lawrenz et al. · Journal of Hypertension · 2010 · 99 citations

Medicine, Cardiology, Pharmacology +12

Evaluation of the Adulticidal Efficacy of Imidacloprid 10 %/Moxidectin 2.5 % (w/v) Spot-on (Advocate®, Advantage® Multi) against Dirofilaria repens in Experimentally Infected Dogs

Gabriele Petry, Marco Genchi, Holger Schmidt et al. · Parasitology Research · 2015 · 40 citations · Full text

Veterinary Medicine, Entomology, Veterinary Parasitology +17

Runcaciguat, a novel soluble guanylate cyclase activator, shows renoprotection in hypertensive, diabetic, and metabolic preclinical models of chronic kidney disease

Agnès Bénardeau, Antje Kahnert, Tibor Schomber et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2021 · 31 citations · Full text

Medicine, Nephrology, Pharmacology +17

1–5 of 8